Perspective Therapeutics (CATX) EBIT (2010 - 2026)
Perspective Therapeutics' EBIT came in at -$29.26 million for Q2 2026, compared with -$24.04 million a year earlier.
Powered by 
Analysis
Perspective Therapeutics (CATX) EBIT (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Perspective Therapeutics reported EBIT of -$121.79 million; for FY2025, it came in at -$113.56 million.
- Going back by year, EBIT was -$90.89 million in FY2024, -$40.94 million in FY2023, -$8.67 million in FY2022 and -$3.45 million in FY2021.
- The five-year range for quarterly EBIT is -$44.98 million (Q4 2024) to $158,000 (Q4 2022).
- Business Quant data shows CATX's EBIT at -$28.28 million (Q1 2026), -$38.28 million (Q4 2025) and -$25.97 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Perspective Therapeutics | 285.22 Mn | 285.22 Mn | - | -29.26 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -29.26 Mn |
| Mar 31, 2026 | -28.28 Mn |
| Dec 31, 2025 | -38.28 Mn |
| Sep 30, 2025 | -25.97 Mn |
| Jun 30, 2025 | -24.04 Mn |
| Mar 31, 2025 | -21.83 Mn |
| Dec 31, 2024 | -44.98 Mn |
| Sep 30, 2024 | -18.63 Mn |
| Jun 30, 2024 | -14.26 Mn |
| Mar 31, 2024 | -13.01 Mn |
| Dec 31, 2023 | -11.68 Mn |
| Sep 30, 2023 | -9.75 Mn |
| Jun 30, 2023 | -9.75 Mn |
| Mar 31, 2023 | -9.76 Mn |
| Dec 31, 2022 | 158,000.00 |
| Sep 30, 2022 | -4.21 Mn |
| Jun 30, 2022 | -2.11 Mn |
| Mar 31, 2022 | -1.38 Mn |
| Dec 31, 2021 | -1.64 Mn |
| Sep 30, 2021 | -2.27 Mn |
API Access
Perspective Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=CATX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "CATX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=CATX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();